U-RNAZ

Q:RNAZ - TRANSCODE THERAPEUTICS INC - Website unknown - click to update

10:21:10 EDT

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
RNAZ - Q	1.0	2.72	·	2.76	0.2	2.74	-0.11	-3.9	43.4	104	142	2.81 2.81 2.72	37.40 3.03	10:02:55	Jun 06	15 min RT 2¢

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
Nasdaq Indicators -- Market: Nasdaq -- Bid Tick: Down -- UPC Restricted: No

Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · 1yr Bulletins · Historical · Options · Portfolio

Recent Trades - Last 10 of 142

More trades...

Time ET	Ex	Price	Change	Volume
10:02:55	Q	2.74	-0.11	329
10:02:53	Q	2.74	-0.11	100
10:02:53	Q	2.74	-0.11	10
10:02:53	Q	2.74	-0.11	221
10:02:34	Q	2.72	-0.13	90
10:02:03	Q	2.735	-0.115	1
10:01:15	Q	2.7352	-0.1148	500
10:01:08	Q	2.7201	-0.1299	85
10:00:57	Q	2.7201	-0.1299	5,151
10:00:38	Q	2.72	-0.13	100

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Date ET	Symbol	Type	Headline
2023-06-06 17:30	U:RNAZ	News Release200	TransCode Therapeutics Announces Pricing of $7 Million Public Offering
2023-06-06 16:01	U:RNAZ	News Release200	TransCode Therapeutics Reports Positive Preclinical Results with its Lead Candidate, TTX-MC138, in Glioblastoma
2023-05-22 07:00	U:RNAZ	News Release200	TransCode Therapeutics Announces 1-for-20 Reverse Stock Split

Date ET

Symbol

Type

Headline

2023-06-06 17:30

U:RNAZ

News Release

TransCode Therapeutics Announces Pricing of $7 Million Public Offering

2023-06-06 16:01

U:RNAZ

News Release

TransCode Therapeutics Reports Positive Preclinical Results with its Lead Candidate, TTX-MC138, in Glioblastoma

2023-05-22 07:00

U:RNAZ

News Release

TransCode Therapeutics Announces 1-for-20 Reverse Stock Split